CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...

Related Keywords

,Compensation Committee ,Biopharma Corp ,Nasdaq ,Incentive Plan ,Nasdaq Listing Rule ,Grant Date ,Pharma Investor ,Cti Biopharma Corp ,